|Day Low/High||42.77 / 44.07|
|52 Wk Low/High||36.65 / 64.50|
At some point the market's inconsistency will resolve itself either way.
I'm all in favor of mergers and acquisitions -- the more we get, the higher the stock market goes -- but I am not in favor of making conclusions based on tips about deals.
Reports of two potentially major buyouts show the risks of late-cycle corporate bond investing.
The RMPIA's 3.8% jump even beat the Nasdaq Composite Index's 3.7% October climb.
The odds of a Fed December rate cut are now very low. I think the marketplace handles that just fine, as long as the statement with this week's expected cut does not sound too tough, or too cautious.
Rest up for a busy week that includes earnings from Apple, Facebook and Starbucks.
RMPIA is up 20.9% in the first nine months of 2019.
In July, the RMPIA climbed 0.6%, bringing its year-to-date return to just over 21%.
We suspect the new short-term uptrend has some degree of validity
There are a number of RMPIA companies that will be beneficiaries of Back to School and holiday spending.
By selling out of big losers prior to the quarter's close, portfolio managers can hide the stocks from clients, but some downtrodden shares could be ripe for bounces next week, so here's my list.
Let's stand back a little and get some perspective on how prices have behaved.
The G-20 Summit in Japan could hold more intrigue than just the planned meeting between President Trump and Xi.
Amid May's market turbulence, the RMPIA was buoyed by the more than 4% rise from Medtronic.
RMPIA outperformed once gain during April.
CVS is setting up an anticipated new stock trajectory for investors.
I've spotlighted three blue-chip companies with stock prices that are at ridiculously low valuations right now.
* If 3M's EPS miss and this column doesn't give you pause for reflection on how investors blindly follow price, nothing will! * Despite protestations from those that worship at the altar of price, share prices are not necessarily truth * Case in poi...
It has become almost too onerous to own something that could be in Amazon's crosshairs.
3M, Walgreens and FedEx had tough reports last quarter. But what they really tell us is to watch fundamentals on earnings.
These 'Bearish Bets' are showing both technical and quantitative deterioration.
The consumer is alive, well, and might benefit from a thaw with China and easy to get jobs. So would Boeing and Caterpillar.
Use the swoon to buy, but wait until the coast is clear and nothing happens and it is just a random rotation.
Look at the entirety of your portfolio and make sure there are no earnings blow-ups coming from the companies that you own.
Instead of fretting about one lukewarm quarter, smart investors should be focused on WBA's absolute value and upside potential.